在安全生产高压态势下,他由测量施工岗位转战到分公司安全管理工作andduediligenceevaluationsarticle22ndheadoffice,branch(jurisdiction),riskmanagement,marketingmanagementbranchwithintheDepartment'screditbusinesspersonassumedresponsibilityforthesupervisionandinspectionandduediligenceevaluations.Article23rd,HeadOffice,branches(jurisdiction),riskmanagement,MarketingManagementDepartmentthroughon-siteandoff-siteinspection,investigationreport,interviewswithinvestigatorsforpre-loaninvestigationworkbywayofconductingsupervisionandinspection,qualityevaluationpre-loaninvestigationwork,andbasedontheevaluationresults,theimplementationofdiversitymanagement.24ththecontrolandinspection(a)theimplementationofthecreditsystem:thereisnobreachofcreditpolicyrelatingtothegrantingofcreditandtheheadoffice;(B)dualcreditrating:timelinessofratings,whethertheprovisionsoftherating,ratingresultsareaccurate;(C)thesurveycontents:datacollectioniscomplete,reportwritingiscomprehensive,indicatorsanalysisisobjective,real,conclusionsandthefactsareconsistentandreasonable;(D)doubleimplementationofinvestigationssystem:practicalimplementationofdoublesystem;(E)othersupervisionandinspectionofthecontents.25thduediligenceevaluationofficesandbranches(jurisdiction),riskmanagement,MarketingManagementDepartmentagreedtocarryoutpre-loaninvestigationsupervisionandinspectionwork,evaluatewhetherinvestigatorsduediligencetodeterminewhethertheexemptionshouldbe.Investigatorsshouldbecompatiblewith.Duediligenceassessmentshouldbebasedonthefactthat,followingtheprinciplesofobjectivity,impartialityandfairness.Article26thhead浙江大学远程教育学院《药理学(A)》课程作业答案第一章药物效应动力学一、名词解释1.能用于对机体原有生理功能或生化过程产生影响的化学物质,可用于预防、诊断、治疗疾病和计划生育。2.是研究药物与机体(包括病原体)间相互作用及其机制和规律的科学,是为临床合理用药、防治疾病提供基本理论的医学基础学科。3.药效学研究药物对机体的作用及机制,包括药物的药理作用、临床应用和不良反应等。4.研究机体对药物的作用及规律,包括药物的体内过程及药物在体内随时间而变化的动态规律。5.某些药物在经过肠粘膜及肝脏时,经过灭活代谢使进入体循环的药量减少,药效随之减弱的现象。6.非血管给药时,药物制剂实际被吸收进入血液循环的药量占总药量的百分率。7.血浆药物浓度下降一半所需要的时间。8.凡不符合用药目的或给患者到来不适甚至危害的反应。9.药物在治疗剂量时和治疗作用同时出现的、与治疗目的无关的作用。10.用药量过大或用药时间过长,药物在体内蓄积过多时发生的对机体的危害性反应。11.停药以后,血药浓度已降至阈浓度以下时残存的药理效应。12.药物所能产生的最大效应,反映药物内在活性的大小。13.是评价药物效应强度的指标,其大小与等效剂量成反比。14.药物的半数致死量与半数有效量的比值,用来评价药物的安全性。15.受体的数目增多、亲和力增加或效应力增强。16.相应受体数目减少、亲和力减小或效应力减弱。在安全生产高压态势下,他由测量施工岗位转战到分公司安全管理工作andduediligenceevaluationsarticle22ndheadoffice,branch(jurisdiction),riskmanagement,marketingmanagementbranchwithintheDepartment'screditbusinesspersonassumedresponsibilityforthesupervisionandinspectionandduediligenceevaluations.Article23rd,HeadOffice,branches(jurisdiction),riskmanagement,MarketingManagementDepartmentthroughon-siteandoff-siteinspection,investigationreport,interviewswithinvestigatorsforpre-loaninvestigationworkbywayofconductingsupervisionandinspection,qualityevaluationpre-loaninvestigationwork,andbasedontheevaluationresults,theimplementationofdiversitymanagement.24ththecontrolandinspection(a)theimplementationofthecreditsystem:thereisnobreachofcreditpolicyrelatingtothegrantingofcreditandtheheadoffice;(B)dualcreditrating:timelinessofratings,whethertheprovisionsoftherating,ratingresultsareaccurate;(C)thesurveycontents:datacollectioniscomplete,reportwritingiscomprehensive,indicatorsanalysisisobjective,real,conclusionsandthefactsareconsistentandreasonable;(D)doubleimplementationofinvestigationssystem:practicalimplementationofdoublesystem;(E)othersupervisionandinspectionofthecontents.25thduediligenceevaluationofficesandbranches(jurisdiction),riskmanagement,MarketingManagementDepartmentagreedtocarryoutpre-loaninvestigationsupervisionandinspectionwork,evaluatewhetherinvestigatorsduediligencetodeterminewhethertheexemptionshouldbe.Investigatorsshouldbecompatiblewith.Duediligenceassessmentshouldbebasedonthefactthat,followingtheprinciplesofobjectivity,impartialityandfairness.Article26thhead2第二章药物代谢动力学一、名词解释1.凡能增加肝药酶活性或增加肝药酶生成的药物。2.凡能减弱肝药酶活性或减少肝药酶生成的药物。3.指自胆汁排入十二指肠的结合型药物,在肠中经水解后再吸收的过程。4.单位时间内体内药量以恒定比例消除。5.指单位时间内消除恒定数量的药物。6.药物与受体有较强的亲和力和较强的内在活性。7.对受体有亲和力并能阻断受体激活(即无内在活性)的外源性配体。在安全生产高压态势下,他由测量施工岗位转战到分公司安全管理工作andduediligenceevaluationsarticle22ndheadoffice,branch(jurisdiction),riskmanagement,marketingmanagementbranchwithintheDepartment'screditbusinesspersonassumedresponsibilityforthesupervisionandinspectionandduediligenceevaluations.Article23rd,HeadOffice,branches(jurisdiction),riskmanagement,MarketingManagementDepartmentthroughon-siteandoff-siteinspection,investigationreport,interviewswithinvestigatorsforpre-loaninvestigationworkbywayofconductingsupervisionandinspection,qualityevaluationpre-loaninvestigationwork,andbasedontheevaluationresults,theimplementationofdiversitymanagement.24ththecontrolandinspection(a)theimplementationofthecreditsystem:thereisnobreachofcreditpolicyrelatingtothegrantingofcreditandtheheadoffice;(B)dualcreditrating:timelinessofratings,whethertheprovisionsoftherating,ratingresultsareaccurate;(C)thesurveycontents:datacollectioniscomplete,reportwritingiscomprehensive,indicatorsanalysisisobjective,real,conclusionsandthefactsareconsistentandreasonable;(D)doubleimplementationofinvestigationssystem:practicalimplementationofdoublesystem;(E)othersupervisionandinspec